Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oculis

19.57
-0.0700-0.36%
Post-market: 19.570.00000.00%17:52 EDT
Volume:51.97K
Turnover:1.02M
Market Cap:918.71M
PE:-8.35
High:19.84
Open:19.20
Low:19.20
Close:19.64
Loading ...

Oculis Publishes Notification of Major Changes in Voting Rights

GlobeNewswire
·
04 Jan

Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors

TIPRANKS
·
26 Dec 2024

TransMedics Stock Plunges 57.5% in Three Months: What's Next?

Zacks
·
14 Dec 2024

2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid

Motley Fool
·
11 Dec 2024

TransMedics Group, Inc. (TMDX): A Bull Case Theory

Insider Monkey
·
10 Dec 2024

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
07 Dec 2024

Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis

GlobeNewswire
·
03 Dec 2024

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

GlobeNewswire
·
29 Nov 2024

Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities

GlobeNewswire
·
27 Nov 2024

2 Hypergrowth Stocks That Are Screaming Buys in November

Motley Fool
·
23 Nov 2024

Is TransMedics Group Stock a Buy?

Motley Fool
·
15 Nov 2024

Lightmatter and Amkor Technology Partner to Build World’s Largest 3D Photonics Package

Business Wire
·
15 Nov 2024

Bank of America Securities Sticks to Its Buy Rating for Oculis Holding (OCS)

TIPRANKS
·
13 Nov 2024

Oculis Holding Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Down 52%, Is TransMedics Stock a Buy on the Dip?

Motley Fool
·
09 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 Nov 2024